Projected Income Statement: Albemarle Corporation

Forecast Balance Sheet: Albemarle Corporation

Forecast Balance Sheet - Albemarle Corporation
Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Net Debt 1 1,955 1,718 3,277 2,324 1,576 694 -71.4 -948
Change - -12.12% 90.75% -29.08% -32.19% -55.95% -110.29% -1,227.73%
Announcement Date 2/16/22 A 2/15/23 A 2/14/24 A 2/12/25 A 2/11/26 A - - -
1USD in Million
Estimates

Cash Flow Forecast: Albemarle Corporation

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
CAPEX 1 953.7 1,262 2,149 1,686 589.8 513.1 626.5 707.7
Change - 32.29% 70.36% -21.56% -65.01% -13.01% 22.1% 12.96%
Free Cash Flow (FCF) 1 -609.4 646.2 -824 -983.7 692.5 1,319 1,321 1,128
Change - 206.04% -227.51% -19.39% 170.39% 90.55% 0.12% -14.65%
Announcement Date 2/16/22 A 2/15/23 A 2/14/24 A 2/12/25 A 2/11/26 A - - -
1USD in Million
Estimates

Forecast Financial Ratios: Albemarle Corporation

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028

Profitability

        
EBITDA Margin (%) 26.17% 47.48% 35.05% 21.2% 21.35% 44.23% 45.4% 43.3%
EBIT Margin (%) 18.54% 43.37% 30.57% 10.25% 8.54% 25.16% 26.35% 28.11%
EBT Margin (%) 4.02% 33.24% 2.57% -32.8% -10.74% 17.92% 20.19% 25.27%
Net margin (%) 3.72% 36.75% 16.36% -24.47% -13.17% 20.65% 25.71% 30.64%
FCF margin (%) -18.31% 8.83% -8.57% -18.29% 13.46% 21.52% 21.19% 17.41%
FCF / Net Income (%) -492.76% 24.02% -52.37% 74.75% -102.23% 104.24% 82.4% 56.82%

Profitability

        
ROA 4.39% 19.57% 15.54% -1.58% -0.56% 8.88% 9.84% 11.64%
ROE 8.31% 19.01% 30.12% -2.84% -0.95% 14.7% 13.66% 12.61%

Financial Health

        
Leverage (Debt/EBITDA) 2.24x 0.49x 0.97x 2.04x 1.43x 0.26x - -
Debt / Free cash flow -3.21x 2.66x -3.98x -2.36x 2.28x 0.53x - -

Capital Intensity

        
CAPEX / Current Assets (%) 28.66% 17.24% 22.35% 31.35% 11.47% 8.37% 10.05% 10.93%
CAPEX / EBITDA (%) 109.49% 36.3% 63.77% 147.91% 53.72% 18.92% 22.13% 25.23%
CAPEX / FCF (%) -156.49% 195.24% -260.85% -171.37% 85.17% 38.89% 47.42% 62.76%

Items per share

        
Cash flow per share 1 2.972 16.2 11.25 5.974 10.9 14.57 12.39 14.07
Change - 445.01% -30.52% -46.91% 82.41% 33.71% -14.94% 13.52%
Dividend per Share 1 1.56 1.58 1.6 1.61 1.62 1.616 1.648 1.664
Change - 1.28% 1.27% 0.63% 0.62% -0.25% 2% 0.94%
Book Value Per Share 1 48.07 67.77 80.17 84.74 80.99 81.37 88.25 101.1
Change - 40.97% 18.3% 5.69% -4.43% 0.47% 8.45% 14.55%
EPS 1 1.06 22.84 13.36 -11.2 -5.76 9.973 10.98 14.5
Change - 2,054.72% -41.51% -183.83% 48.57% 273.14% 10.05% 32.12%
Nbr of stocks (in thousands) 116,976 117,153 117,353 117,540 117,698 118,005 118,005 118,005
Announcement Date 2/16/22 A 2/15/23 A 2/14/24 A 2/12/25 A 2/11/26 A - - -
1USD
Estimates
2026 *2027 *
P/E 10.5x 9.51x
PBR 1.28x 1.18x
EV / Sales 2.12x 1.96x
Yield 1.55% 1.58%

EPS & Dividend

EPS & Dividend - Albemarle Corporation


Y-o-Y evolution of P/E

Valuation ratios - P/E - Albemarle Corporation
 

Year-on-year evolution of the Yield

Valuation ratios - Yield - Albemarle Corporation
Trader
Investor
Global
Quality
ESG MSCI
BBB
Ratings Surperformance© - Albemarle Corporation
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
22
Last Close Price
104.37USD
Average target price
169.81USD
Spread / Average Target
+62.70%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Albemarle Corporation
  1. Stock Market
  2. Stocks
  3. ALB Stock
  4. Financials Albemarle Corporation